WO2002046362A3 - Gene associated with benign prostatic hyperplasia in humans - Google Patents

Gene associated with benign prostatic hyperplasia in humans Download PDF

Info

Publication number
WO2002046362A3
WO2002046362A3 PCT/US2001/045826 US0145826W WO0246362A3 WO 2002046362 A3 WO2002046362 A3 WO 2002046362A3 US 0145826 W US0145826 W US 0145826W WO 0246362 A3 WO0246362 A3 WO 0246362A3
Authority
WO
WIPO (PCT)
Prior art keywords
benign prostatic
prostatic hyperplasia
humans
gene associated
bph
Prior art date
Application number
PCT/US2001/045826
Other languages
French (fr)
Other versions
WO2002046362A2 (en
Inventor
William E Munger
Prakash Kulkarni
Robert H Getzenberg
Original Assignee
Gene Logic Inc
Japan Tobacco Inc
William E Munger
Prakash Kulkarni
Robert H Getzenberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Logic Inc, Japan Tobacco Inc, William E Munger, Prakash Kulkarni, Robert H Getzenberg filed Critical Gene Logic Inc
Priority to AU2002239466A priority Critical patent/AU2002239466A1/en
Publication of WO2002046362A2 publication Critical patent/WO2002046362A2/en
Publication of WO2002046362A3 publication Critical patent/WO2002046362A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates generally to the changes in gene expression in Benign Prostatic Hyperplasia (BPH). The invention relates specifically to a human gene family which is differentially expressed in BPH compared to normal prostate tissue.
PCT/US2001/045826 2000-12-06 2001-12-06 Gene associated with benign prostatic hyperplasia in humans WO2002046362A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002239466A AU2002239466A1 (en) 2000-12-06 2001-12-06 Gene associated with benign prostatic hyperplasia in humans

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25142000P 2000-12-06 2000-12-06
US60/251,420 2000-12-06

Publications (2)

Publication Number Publication Date
WO2002046362A2 WO2002046362A2 (en) 2002-06-13
WO2002046362A3 true WO2002046362A3 (en) 2003-01-16

Family

ID=22951895

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/045826 WO2002046362A2 (en) 2000-12-06 2001-12-06 Gene associated with benign prostatic hyperplasia in humans

Country Status (2)

Country Link
AU (1) AU2002239466A1 (en)
WO (1) WO2002046362A2 (en)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 10 August 2000 (2000-08-10), LAMERDIN ET AL., XP002952348, Database accession no. (AC011545.4) *
DATABASE GENBANK [online] 11 June 1999 (1999-06-11), LAMERDIN ET AL., XP002952349, Database accession no. (AC007785.1) *
DATABASE GENBANK [online] 24 February 2000 (2000-02-24), STRAUSBERG, XP002952347, Database accession no. (AW469104.1) *
DATABASE GENBANK [online] 8 September 1999 (1999-09-08), STRAUSBERG, XP002952346, Database accession no. (AI992127.1) *
WATSON ET AL.: "Recombinant DNA", 1994, W.H. FREEMAN AND COMPANY, NEW YORK, XP002933101 *

Also Published As

Publication number Publication date
WO2002046362A2 (en) 2002-06-13
AU2002239466A1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
AU2003224960A1 (en) Steam reforming fuel processor, burner assembly, and methods of operating the same
NO993396L (en) Quinoline and quinoline compounds useful in therapy, especially in the treatment of benign prostatic hyperplasia
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
WO2001060860A3 (en) Genes differentially expressed in human prostate cancer and their use
WO2001097829A3 (en) Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
AU2001280653A1 (en) Venturi cluster, and burners and methods employing such cluster
AU4678601A (en) Resectoscope
WO2003032916A3 (en) Organosulfur inhibitors of tyrosine phosphatases
AUPQ923100A0 (en) Treatment of prostate cancer
IL141235A0 (en) Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi
WO2002044360A3 (en) Modified arginine deiminase
EP1743656A3 (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
AU2001284739A1 (en) Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
HK1085373A1 (en) Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms
WO2002046362A3 (en) Gene associated with benign prostatic hyperplasia in humans
WO2002036826A3 (en) Del-1 and benign prostatic hyperplasia
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
WO2002077162A3 (en) Gene (t23490) associated with benign prostatic hyperplasia
WO2002048173A3 (en) Expression of a cadherin-like protein in benign prostatic hyperplasia
WO2003008561A3 (en) Genes associated with benign prostatic hyperplasia
WO2001098456A3 (en) IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
AU2001249974A1 (en) Venturi style burner
AU2001275264A1 (en) Treatment of fibrous substrates with silsesquioxanes and stainblockers
WO2001030804A3 (en) Salt form of a conjugate useful in the treatment of prostate cancer
AU2001283152A1 (en) Identification of cdnas associated with benign prostatic hyperplasia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP